Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biomarin Pharmaceuticals (NQ: BMRN )

65.14 +0.88 (+1.36%)
Streaming Delayed Price Updated: 10:53 AM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Other Filings

< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Form SC TO-T/A
Source: SEC/Edgar
January 12, 2015
Form SC TO-T/A
Source: SEC/Edgar
January 05, 2015
Form SC TO-T/A
Source: SEC/Edgar
December 30, 2014
Form SC TO-T/A
Source: SEC/Edgar
December 23, 2014
Form 8-K
Source: SEC/Edgar
December 22, 2014
Form SC TO-T
Source: SEC/Edgar
December 11, 2014
Form SC TO-C
Source: SEC/Edgar
December 09, 2014
Form 8-K/A
Source: SEC/Edgar
December 09, 2014
Form SC TO-C
Source: SEC/Edgar
December 09, 2014
Form SC TO-C
Source: SEC/Edgar
November 30, 2014
Form SC TO-C
Source: SEC/Edgar
November 25, 2014
Form SC TO-C
Source: SEC/Edgar
November 25, 2014
Form 8-K
Source: SEC/Edgar
November 25, 2014
Form SC TO-C
Source: SEC/Edgar
November 23, 2014
Form SC TO-C
Source: SEC/Edgar
November 23, 2014
Form 8-K
Source: SEC/Edgar
November 23, 2014
Form 8-K
Source: SEC/Edgar
October 22, 2014
Form 8-K
Source: SEC/Edgar
October 13, 2014
Form 8-K/A
Source: SEC/Edgar
August 25, 2014
Form 8-K
Source: SEC/Edgar
July 31, 2014
Form S-8
Source: SEC/Edgar
July 30, 2014
Form 8-K
Source: SEC/Edgar
July 29, 2014
Form 8-K
Source: SEC/Edgar
June 09, 2014
Form 8-K
Source: SEC/Edgar
April 30, 2014
Form ARS
Source: SEC/Edgar
April 23, 2014
Form DEF 14A
Source: SEC/Edgar
April 21, 2014
Form DEFA14A
Source: SEC/Edgar
April 21, 2014
Form 8-K
Source: SEC/Edgar
March 24, 2014
Form NO ACT
Source: SEC/Edgar
March 13, 2014
Form 8-K
Source: SEC/Edgar
March 12, 2014
< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.